Erythropoietin and intravenous iron therapy in postpartum anaemia

Acta Obstetricia et Gynecologica Scandinavica

Volumn 86, Issue 8, 2007, Pages 957-962

  Wågström, Elle ^a   Åkesson, Agneta ^c   Van Rooijen, Marianne ^b   Larson, Barbro ^b   Bremme, Katarina ^b  

^a STOCKHOLM SÖDER HOSPITAL   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Iron sucrose haemoglobin; Postpartum anaemia; Pregnancy; Recombinant human erythropoietin

Indexed keywords

FERRIC HYDROXIDE SUCROSE; HEMOGLOBIN; IRON; RECOMBINANT ERYTHROPOIETIN;

ADULT; ANEMIA; ARTICLE; BIRTH; BLOOD PRESSURE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; INFLAMMATION; PATIENT ASSESSMENT; POSTPARTUM ANEMIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADULT; ANEMIA; DRUG THERAPY, COMBINATION; ERYTHROPOIETIN; FEMALE; HEMOGLOBINS; HUMANS; INFUSIONS, INTRAVENOUS; IRON; PILOT PROJECTS; PREGNANCY; PROSPECTIVE STUDIES; PUERPERAL DISORDERS; RECOMBINANT PROTEINS; TREATMENT OUTCOME;

EID: 34547194641     PISSN: 00016349     EISSN: 16000412     Source Type: Journal    
DOI: 10.1080/00016340701446157     Document Type: Article

References (12)

1. American College of Obstetricians and Gynecologists. ACOG educational bulletin. Postpartum hemorrhage. Number 243, January 1998 (replaces No. 143, July 1990). Int J Gynaecol Obstet. 1998;61(1):79-86.
2. Williamson LM, Lowe S, Love EM, Cohen H, Soldan K, McClelland DB, et al. Serious hazards of transfusion (SHOT) initiative: analysis of the first two annual reports. BMJ. 1999;319(7201):16-9.
3. Cazzola M, Mercuriali F, Brugnara C. Use of recombinant human erythropoietin outside the setting of uremia. Blood. 1997;89(12):4248-67.
4. Larson B, Bremme K, Clyne N, Nordstrom L. Preoperative treatment of anemic women with epoetin beta. Acta Obstet Gynecol Scand. 2001;80(6):559-62.
5. Breymann C, Richter C, Huttner C, Huch R, Huch A. Effectiveness of recombinant erythropoietin and iron sucrose vs. iron therapy only, in patients with postpartum anaemia and blunted erythropoiesis. Eur J Clin Invest. 2000;30(2):154-61.
6. Kotto-Kome AC, Calhoun DA, Montenegro R, Sosa R, Maldonado L, Christensen RD. Effect of administering recombinant erythropoietin to women with postpartum anemia: a meta-analysis. J Perinatol. 2004;24(1):11-5.
7. Akesson A, Bjellerup P, Vahter M. Evaluation of kits for measurement of the soluble transferrin receptor. Scand J Clin Lab Invest. 1999;59(2):77-81.
8. Broche D-E, Gay C, Armand-Branger S, Grangeasse L, Terzibachian J-J. Severe anaemia in the immediate postpartum period. Clinical practice and value of intervenous iron. Eur J Obstet Gynecol Repr Biol. 2005;123:S21-7.
9. Beguin Y, Lipscei G, Thoumsin H, Fillet G. Blunted erythropoietin production and decreased erythropoiesis in early pregnancy. Blood. 1991;78(1):89-93.
10. Koury MJ, Bondurant MC. Control of red cell production: the roles of programmed cell death (apoptosis) and erythropoietin. Transfusion. 1990;30(8):673-4.
11. Vergouwen PC, Collee T, Marx JJ. Haematocrit in elite athletes. Int J Sports Med. 1999;20(8):538-41.
12. Bhandal N, Russel R. Intravenous versus oral iron therapy for postpartum anaemia. BJOG. 2006;113(11):1248-52.